TELIX Aktie

 

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

MELBOURNE, Australia and INDIANAPOLIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patients in the United States (U.S.) have been dosed with Pixclara® (floretyrosine F 18 or 18F-FET), its FDA-approved, amino acid positron emission tomography (PET) drug for glioma (brain cancer) imaging....

IBA to offer QUANTM® Irradiation System solid-target technology to cyclotron users worldwide, scaling local production of radiometals for theranostics...

The average of price targets set by Wall Street analysts indicates a potential upside of 83.4% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock....

Telix Pharmaceuticals shares are in the spotlight after the FDA granted Fast Track for its BiPASS pre-biopsy prostate cancer imaging program. The post Telix Pharmaceuticals wins FDA Fast Track for BiPASS prostate cancer imaging appeared first on The Motley Fool Australia....

Here's what Mark Gardner from MPC Markets thinks of these three ASX shares. The post Buy, hold, sell: Telix Pharmaceuticals, Qualitas, Greatland Resources shares appeared first on The Motley Fool Australia....

Bildnachweis: bmf-foto.de – stock.adobe.com, stock3.com. Der australische Radiopharma-Konzern Telix Pharmaceuticals Limited und ITM Isotope Technologies Munich SE schließen sich zusammen. Die Transaktion bewertet ITM zunächst mit 1,65 Mrd. USD, weitere […] Der Beitrag Telix und ITM: Fusion formt Radiopharma-Schwergewicht erschien zuerst auf GoingPublic.de....

Three experts share their views on three ASX 200 shares. The post Buy, hold, sell: New Hope, REA, Telix Pharmaceuticals shares appeared first on The Motley Fool Australia....

And find out which has the strongest upside ahead. The post Telix Pharmaceuticals vs Ramsay Healthcare: Which ASX healthcare stock made investors richer in 2026? appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Here is the latest outlook from Bell Potter. The post What is this broker's view on Telix shares after yesterday's crash? appeared first on The Motley Fool Australia....

Integration, regulatory milestones and dilution are the real tests now. The post Telix shares just crashed 12% on merger news. Time to buy the dip? appeared first on The Motley Fool Australia....

Die australische Telix blättert für den Münchner Rivalen ITM bis zu 2,35 Mrd. Dollar hin. Der Käufer rechnet dank technologischer Fortschritte, die den Einsatz von radioaktiven Substanzen in der Pharmazie wirtschaftlicher machen, mit einer wachsenden Nachfrage....

Bildnachweis: bmf-foto.de – stock.adobe.com, stock3.com. Der australische Radiopharma-Konzern Telix Pharmaceuticals Limited übernimmt ITM Isotope Technologies Munich SE für eine Vorab-Bewertung von 1,65 Mrd. USD. Ein wesentlicher Teil dessen, was ITM […] Der Beitrag Telix kauft ITM: Was vom Milliardendeal in München bleibt erschien zuerst auf GoingPublic.de....

Find insight on HaItian International, Telix Pharmaceuticals and more in the latest Market Talks covering Health Care....

The Australian company will pay $1.65bn upfront on a cash-free, debt-free basis. An additional $700m may be payable if ITM-11 meets specified regulatory approval and sales milestones. The The post Telix to acquire ITM in deal worth up to $2.35bn appeared first on Pharmaceutical Business review....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

CANBERA (dpa-AFX) - Telix Pharmaceuticals Ltd. (TLX,TLX.AX) announced that it signed an agreement to acquire privately held ITM Isotope Technologies Munich SE in a transaction valued at up to US$2......

Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive......